CR

Chintu Rout

Active Director Director DIN 09047641
DIN 09047641 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Chintu Rout

Data last updated:

Chintu Rout is a Director at Pferd Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Pferd Pharmaceutical Private Limited reported revenue of ₹88.4 Lakh (FY 2024).

DIN 09047641
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2021
Oldest Company Age 5 yrs
Largest company Pferd Pharmaceutical Private Limited · ₹88.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pferd Pharmaceutical Private Limited U24239OR2021PTC035485
Director01 Feb 20212021₹88.4 Lakh (FY 2024)Active

Board colleagues of Chintu Rout

Directorship timeline

Open interactive timeline →
Pferd Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Chintu Rout

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintu Rout

Chintu Rout currently holds 1 directorship: Pferd Pharmaceutical Private Limited (Director, since 01 Feb 2021, revenue ₹88.4 Lakh (FY 2024)).

Chintu Rout was first appointed on 01 Feb 2021 as Director at Pferd Pharmaceutical Private Limited.

The current boards of Chintu Rout's companies include Mona Priyadarshini (Pferd Pharmaceutical Private Limited), Nirmalendu Mangaraj (Pferd Pharmaceutical Private Limited), Pradip Kumar Barik (Pferd Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available